Unknown

Dataset Information

0

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.

ABSTRACT:

SUBMITTER: Jain T 

PROVIDER: S-EPMC8224498 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.
| S-EPMC2964008 | biostudies-other
Unknown Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
| S-EPMC5193224 | biostudies-literature
Unknown Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a systematic review and meta-analysis.
| S-EPMC5092068 | biostudies-literature
Unknown Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
| S-EPMC7687790 | biostudies-literature
Unknown Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphoma.
| S-EPMC5889038 | biostudies-literature
Unknown Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma.
| S-EPMC7993097 | biostudies-literature
Unknown Transplant strategies in relapsed/refractory Hodgkin lymphoma.
| S-EPMC5897866 | biostudies-literature
Unknown Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era.
| S-EPMC4935530 | biostudies-literature
Unknown Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation.
| S-EPMC7290321 | biostudies-literature
Unknown Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma.
| S-EPMC8297052 | biostudies-literature